Moneycontrol PRO
LAMF
LAMF

Piramal Pharma Shares Surge 4.85% on High Trading Volume

With the stock showing significant movement and positive sentiment, investors will be closely monitoring Piramal Pharma's performance in the coming sessions.
March 25, 2025 / 10:28 IST
Disclaimer This is an AI-assisted live blog with updates sourced from multiple news outlets and agencies Disclaimer
Piramal Pharma Shares Surge 4.85% on High Trading Volume

In today's session, Piramal Pharma experienced a notable surge, climbing 4.85% to reach Rs 230.20. This increase was accompanied by significantly higher trading volumes compared to the average, signaling strong investor interest and market activity.

The stock's performance is particularly noteworthy considering its inclusion in several key indices, including the NIFTY 500, NIFTY Smallcap 100, NIFTY MIDSMALLCAP 400, NIFTY SMALLCAP 50, NIFTY SMALLCAP 250, and Nifty Total Market. This broad representation across various market segments underscores the company's significance within the Indian equity landscape.

Sentiment Analysis

Recent sentiment analysis indicates a bullish to very bullish outlook on Piramal Pharma. Over the past week, the stock has maintained positive sentiment:

  • March 18, 2025: Bullish, closing price at Rs 212.85
  • March 19, 2025: Very Bullish, closing price at Rs 218.50
  • March 20, 2025: Bullish, closing price at Rs 221.29
  • March 21, 2025: Very Bullish, closing price at Rs 226.83
  • March 25, 2025: Very Bullish, closing price at Rs 229.90

Financial Snapshot

A review of Piramal Pharma's financial performance reveals the following:

Financial MetricDec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Revenue (Cr)Rs 1,958.57Rs 2,552.36Rs 1,951.14Rs 2,241.75Rs 2,204.22
Net Profit (Cr)-Rs 3.84Rs 89.23-Rs 111.04Rs 5.33-Rs 13.37
EPS0.080.77-0.670.170.03

The company's annual performance shows:

Financial Metric2021202220232024
Revenue (Cr)Rs 6,314.90Rs 6,559.10Rs 7,081.55Rs 8,171.16
Net Profit (Cr)Rs 787.79Rs 316.93-Rs 240.79-Rs 41.67
EPS18.563.19-1.570.14
BVPS56.3556.4756.7659.80
ROE14.895.61-2.750.22
Debt to Equity0.480.600.810.58

Key financial ratios for March 2024 include a P/E ratio of 920.71, a P/B ratio of 2.16, and a Debt to Equity ratio of 0.58.

With the stock showing significant movement and positive sentiment, investors will be closely monitoring Piramal Pharma's performance in the coming sessions.

Alpha Desk
first published: Mar 25, 2025 10:28 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347